Tengion Announces Continued Clinical Progress on Key Milestones for Neo-Urinary Conduit™
June 11, 2012 - (Tengion) - “Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced continued clinical progress on key milestones for the ongoing Phase 1 trial of the Company's most advanced product candidate, the Neo-Urinary Conduit.” Read Full Article
